Akebia Therapeutics Inc. Stock
Price
Target price
€1.22
€1.22
-1.770%
-0.022
-1.770%
€3.60
16:42 / Tradegate
WKN: A1XF0S / Symbol: AKBA / Name: Akebia / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Akebia
sharewise wants to provide you with the best news and tools for Akebia, so we directly link to the best financial data sources.
Financials
News
Akebia Therapeutics Surges on FDA Approval for Anemia Treatment
Akebia Therapeutics Inc. (NASDAQ: AKBA) is a biopharmaceutical company specializing in developing treatments for chronic kidney diseases (CKD) and anemia management for patients with CKD. The